Pro/con clinical debate: Hydroxyethylstarches should be avoided in septic patients

Critical Care

Volumn 7, Issue 4, 2003, Pages 279-281

  Schortgen, Frédérique ^a   Brochard, Laurent ^b   Burnham, Ellen ^c   Martin, Greg S ^c  

^a BICHAT HOSPITAL   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GELATIN; HETASTARCH; INFUSION FLUID;

ACUTE KIDNEY FAILURE; ARTICLE; BLOOD CLOTTING DISORDER; CAPILLARY LEAK SYNDROME; CRYSTALLOID; DRUG EXCRETION; DRUG HALF LIFE; HUMAN; INTENSIVE CARE UNIT; MICROCIRCULATION; NEPHROTOXICITY; ONCOTIC PRESSURE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PRURITUS; RESUSCITATION; SEPSIS; SEPTIC SHOCK; TREATMENT OUTCOME;

CARDIAC OUTPUT; FRANCE; HETASTARCH; HUMANS; INTENSIVE CARE; SEPSIS;

EID: 0041695529     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc1885     Document Type: Article

References (25)

1. Ernest D, Belzberg AS, Dodek PM: Distribution of normal saline and 5% albumin infusions in septic patients. Crit Care Med 1999, 27:46-50.
2. Rackow EC, Falk JL, Fein IA, Siegel JS, Packman MI, Haupt MT Kaufman BS, Putnam D: Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med 1983, 11:839-850.
3. Choi PT, Yip G, Quinonez LG, Cook DJ: Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 1999, 27:200-210.
4. Marik PE, Iglesias J: Would the colloid detractors please sit down! [Editorial.] Crit Care Med 2000, 28:2652-2654.
5. Boldt J, Heesen M, Muller M, Pabsdorf M, Hempelmann G: The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg 1996, 83:254-261.
6. 2 gradient or gastric intramucosal pH in patients who have sepsis syndrome. Crit Care Med 2000, 28: 2254-2258.
7. Asfar P, Kerkeni N, Labadie F, Gouello JP, Brenet O, Alquier P: Assessment of hemodynamic and gastric mucosal acidosis with modified fluid versus 6% hydroxyethyl starch: a prospective, randomized study. Intensive Care Med 2000, 26:1282-1287.
8. Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P: Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996, 348:1620-1622.
9. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L: Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001, 357:911-916.
10. Kimme P, Jannsen B, Ledin T, Gupta A, Vegfors M: High incidence of pruritus after large doses of hydroxyethyl starch (HES) infusions. Acta Anaesthesiol Scand 2001, 45:686-689.
11. Wilkes MM, Navickis RJ, Sibbald WJ: Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg 2001, 72: 527-533, discussion 534.
12. Christidis C, Mal F, Ramos J, Senejoux A, Callard P, Navarro R, Trinchet JC, Larrey D, Beaugrand M, Guettier C: Worsening of hepatic dysfunction as a consequence of repeated hydroxyethylstarch infusions. J Hepatol 2001, 35:726-732.
13. Treib J, Baron JF, Grauer MT, Strauss RG: An international view of hydroxyethyl starches. Intensive Care Med 1999, 25:258-268.
14. Jamnicki M, Zollinger A, Seifert B, Popovic D, Pasch T, Spahn DR: Compromised blood coagulation: an in vitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.5 using thrombelastography. Anesth Analg 1998, 87:989-993.
15. Boldt J, Muller M, Mentges D, Papsdorf M, Hempelmann G: Volume therapy in the critically ill: is there a difference? Intensive Care Med 1998, 24:28-36.
16. Starling EH: On the absorption of fluid from connective tissue spaces. J Physiol (London) 1896, 19:312-326.
17. Kaminsky MV Jr, Haase TJ: Albumin and colloid osmotic pressure implications for fluid resuscitation. Crit Care Clin 1992, 8: 311-321.
18. Marx G, Cobas-Meyer M, Schuerholz T, Vangerow B, Gratz KF, Hecker H, Sumpelmann R, Rueckoldt H, Leuwer M: Hydroxyethyl starch and modified fluid gelatin maintain plasma volume in a porcine model of septic shock with capillary leakage. Int Care Med 2002, 28:629-635.
19. Kellum JA: Fluid resuscitation and hyperchloremic acidosis in experimental sepsis: improved short-term survival and acid-base balance with Hextend compared to saline. Crit Care Med 2002, 30:300-305.
20. Mangialardi RJ, Martin GS, Bernard GR, Wheeler AP, Christman BW, Dupont WD, Higgins SB, Swindell BB: Hypoproteinemia predicts acute respiratory distress syndrome development, weight gain, and death in patients with sepsis. Crit Care Med 2000, 28:3137-3145.
21. Boldt J, Muller M, Heesen M, Neumann K, Hempelmann GG: Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients. Crit Care Med 1996, 24:385-391.
22. Boldt J, Muller M, Menges T, Papsdorf M, Hempelmann G: Influence of different volume therapy regimens on regulators of circulation in the critically ill. Br J Anaesth 1996, 77:480-487.
23. Boldt J, Heesen M, Welters I, Padberg W, Martin K, Hempelmann G: Does the type of volume therapy influence endothelial-related coagulation in the critically ill? Br J Anaesth 1995, 75: 740-746.
24. Guyton AC, Lindsey AW: Effect of elevated left atrial pressure and decreased plasma protein concentration on the development of pulmonary edema. Circ Res 1959, 7:649-657.
25. Rhee P, Wang D, Ruff P, Austin B, DeBraux S, Wolcott K, Burris D, Ling G, Sun L: Human neutrophil activation and increased adhesion by various resuscitation fluids. Crit Care Med 2000, 28:74-78.